Abstract
To validate if deterioration in reproductive hormone profile of women reporting for fertility treatment may be responsible for increased endocrine anomalies and stagnant success rates post-IVF despite clinical, embryological and technical advances.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
